In addition, in our in vitro studies, we found that atorvastatin combined with low-dose dexamethasone could protect endothelial cells from hematoma injury and that KLF-2 played pivotal roles in the effects of the combined therapy [6, 7]. The gene discussed is KLF2; the disease is hematoma.